glp-1 treatment monroe Agonists: A Comprehensive Overview metabolic health PolitiFact | Realities of life

Pierce, B

Based on positive clinical trial results, Novo Nordisk recently received approval from the FDA to add a new indication to Victoza: lowering cardiovascular risks in type 2 diabetes patients with established cardiovascular disease [178]

But users of the injection medications may also face increased risks for pancreatitis and kidney conditions, among other illnesses

It does not provide medical advice, replace a licensed clinician, or guarantee weight-loss results

Myth: Morning injections are more effective than evening ones Clinical data does not support this

All this to say: Andel helps employers offer these drugs as a workplace benefit to their employees at a more affordable cost